Posted in | News | Chemistry

Rigaku Expands Chemical Threat Analysis With New, Targeted Capabilities

Rigaku Analytical Devices is pleased to announce the launch of the CQL Gen-ID handheld 1064 nm Raman analyzer for the chemical analysis of common threats. The CQL Gen-ID analyzer has the ability to identify unknown solids, liquids, powders, pastes, or gels—through translucent packaging.  

The CQL Gen-ID contains a comprehensive library of narcotics, explosives, household chemicals, precursors, and more for use by customs agencies, as well as crime and clandestine laboratories. 

 

Image credit: Rigaku

The CQL Gen-ID provides the following unique features: 

  • Automatic mixture analysis of up to five components
  • Identification of bulk and trace levels of substances (with optional QuickDetect)
  • Addition of pictorial evidence using an on-board camera for traceability
  • Adjustable nose cone to scan through different thickness and types of packaging
  • Integrated Chemwatch SDS information
  • Pre-configured setting selections based on application
  • Three years of warranty coverage

In addition, users of the CQL Gen-ID will be able to take advantage of Rigaku’s new CommandSuite Software, an integrated fleet management capability that allows for centralized configuration and administration of connected and remote CQL analyzers. This includes upgrading between instrument software, synchronizing user lists, user libraries, and downloading spectra and log files.  CommandSuite is now available on all ResQ CQL devices with software version 2.0.6 and higher.

The goal of the Rigaku CQL Gen-ID was to provide a cost-effective solution for agencies looking for targeted threat analysis of more general or common threats,” said Chris Langford, VP Marketing & Product Management. “We have identified a customer base that may not need all library categories and applications, and so we wanted to ensure we have a chemical analysis solution that meets their needs and price point.”

The CQL Gen-ID is based on Rigaku’s award-winning ResQ and subsequent ResQ CQL 1064 nm Raman platform, used by first responders, law enforcement, and the military to reduce fluorescence interference in high-stress environments.

The Rigaku CQL Gen-ID is supported by Rigaku’s global sales and support distribution channels, offering 24/7 Reachback support, and access to spectral library and software updates.

For more information on the CQL Gen-ID and CommandSuite, please visit: www.rigakuanalytical.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Corporation. (2023, April 05). Rigaku Expands Chemical Threat Analysis With New, Targeted Capabilities. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=61109.

  • MLA

    Rigaku Corporation. "Rigaku Expands Chemical Threat Analysis With New, Targeted Capabilities". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=61109>.

  • Chicago

    Rigaku Corporation. "Rigaku Expands Chemical Threat Analysis With New, Targeted Capabilities". AZoM. https://www.azom.com/news.aspx?newsID=61109. (accessed November 21, 2024).

  • Harvard

    Rigaku Corporation. 2023. Rigaku Expands Chemical Threat Analysis With New, Targeted Capabilities. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=61109.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.